Skip to content

Study on the Screening of mCNV Susceptibility Genes and Their Correlation with Environmental Factors and Traditional Chinese Medicine Constitution

Study on the Screening of mCNV Susceptibility Genes and Their Correlation with Environmental Factors and Traditional Chinese Medicine Constitution

Status
Active, not recruiting
Phases
Unknown
Study type
Observational
Source
ChiCTR
Registry ID
ChiCTR2500106431
Enrollment
Unknown
Registered
2025-07-23
Start date
2025-07-23
Completion date
Unknown
Last updated
2025-08-18

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Myopic Choroidal Neovascularization

Interventions

Myopic choroidal neovascularization:None
Simple high myopia:None

Sponsors

Eye Hospital China Academy of Chinese Medical Science
Lead Sponsor

Eligibility

Sex/Gender
All
Age
18 Years to 60 Years

Inclusion criteria

Inclusion criteria: ?1.Case group inclusion criteria:?? (1) Meeting the diagnostic criteria for myopic choroidal neovascularization(mCNV); (2) Aged 18–60 years; (3) Relatively clear refractive media without affecting fundus examination; (4) Voluntary participation with signed informed consent. 2.??Control group inclusion criteria:?? (1) Meeting the diagnostic criteria for simple high myopia; (2) Aged 18–60 years; (3) No other ocular diseases except refractive error; (4) Voluntary participation with signed informed consent.

Exclusion criteria

Exclusion criteria: 1.Case group exclusion criteria:?? (1) History of ocular trauma or eye surgery; (2) Presence of tractional myopic maculopathy, including vitreomacular traction, macular schisis, macular hole, or retinal detachment; (3) Other ocular diseases that may cause CNV (e.g., AMD, diabetic retinopathy, central exudative chorioretinopathy); (4) Other vision-impairing ocular conditions (e.g., glaucoma, central serous chorioretinopathy, retinal vascular diseases, uveitis); (5) Severe cardiovascular/cerebrovascular diseases or psychiatric disorders; (6) Pregnant or lactating women. ??2.Control group exclusion criteria:?? (1) History of ocular trauma or eye surgery; (2) Intraocular pressure =21 mmHg; (3) Visual field defects; (4) High myopia complications (e.g., retinoschisis, CNV); (5) Severe cardiovascular/cerebrovascular diseases or psychiatric disorders; (6) Pregnant or lactating women.

Design outcomes

Primary

MeasureTime frame
Gene;Constitution of Traditional Chinese Medicine;

Secondary

MeasureTime frame
Uncorrected distance visual acuity;Best corrected distance visual acuity;Intraocular pressure;Equivalent spherical lens degree;Eye axis;Corneal curvature;Central macular thickness;Subfoveal choroidal thickness;Superficial capillary plexus vessel density;Deep capillary plexus vascular density;Choroidal capillary plexus vascular density;The area of the foveal avascular zone;Environmental factor indicators;Anxiety and depression scale score;Quality of life scale score;

Countries

China

Contacts

Public ContactKang Zefeng

Eye Hospital China Academy of Chinese Medical Science

kangzf7717@126.com+86 135 5259 7717

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026